First Header Logo Second Header Logo

Connection

Robert Stratta to Acute Disease

This is a "connection" page, showing publications Robert Stratta has written about Acute Disease.
Connection Strength

0.280
  1. Farney AC, Rogers J, Stratta RJ. Pancreas graft thrombosis: causes, prevention, diagnosis, and intervention. Curr Opin Organ Transplant. 2012 Feb; 17(1):87-92.
    View in: PubMed
    Score: 0.095
  2. Stratta RJ, Alloway RR, Lo A, Hodge EE. A prospective, randomized, multicenter study evaluating the safety and efficacy of two dosing regimens of daclizumab compared to no antibody induction in simultaneous kidney-pancreas transplantation: results at 3 years. Transplant Proc. 2005 Oct; 37(8):3531-4.
    View in: PubMed
    Score: 0.061
  3. Stratta RJ. Late acute rejection episodes after vascularized pancreas transplantation. Transplant Proc. 1998 Jun; 30(4):1560-1.
    View in: PubMed
    Score: 0.037
  4. Stratta RJ. Late acute rejection after pancreas transplantation. Transplant Proc. 1998 Mar; 30(2):646.
    View in: PubMed
    Score: 0.036
  5. Gaber LW, Stratta RJ, Lo A, Egidi MF, Shokouh-Amiri MH, Grewal HP, Kizilisik TA, Gaber AO. Role of surveillance biopsies in monitoring recipients of pancreas alone transplants. Transplant Proc. 2001 Feb-Mar; 33(1-2):1673-4.
    View in: PubMed
    Score: 0.011
  6. Lo A, Stratta RJ, Egidi MF, Shokouh-Amiri MH, Grewal HP, Kizilisik AT, Alloway RR, Gaber AO. Outcome of simultaneous kidney-pancreas transplantation in African-American recipients: a case control study. Transplant Proc. 2001 Feb-Mar; 33(1-2):1675-7.
    View in: PubMed
    Score: 0.011
  7. Lo A, Stratta RJ, Alloway RR, Egidi MF, Shokouh-Amiri MH, Grewal HP, Gaber AO. Limited benefits of induction with monoclonal antibody to interleukin-2 receptor in combination with tacrolimus, mycophenolate mofetil, and steroids in simultaneous kidney-pancreas transplantation. Transplant Proc. 2001 Feb-Mar; 33(1-2):1701-3.
    View in: PubMed
    Score: 0.011
  8. Klintmalm GB, Goldstein R, Gonwa T, Wiesner RH, Krom RA, Shaw BW, Stratta R, Ascher NL, Roberts JW, Lake J, et al. Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group. Transplant Proc. 1993 Feb; 25(1 Pt 1):641-3.
    View in: PubMed
    Score: 0.006
  9. Klintmalm GB, Goldstein R, Gonwa T, Wiesner RH, Krom RA, Shaw BW, Stratta R, Ascher NL, Roberts JW, Lake J, et al. Use of Prograf (FK 506) as rescue therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group. Transplant Proc. 1993 Feb; 25(1 Pt 1):679-88.
    View in: PubMed
    Score: 0.006
  10. Shaw BW, Markin R, Stratta R, Langnas A, Donovan J, Sorrell M. FK 506 for rescue treatment of acute and chronic rejection in liver allograft recipients. Transplant Proc. 1991 Dec; 23(6):2994-5.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.